These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21185657)

  • 21. Impact of angiographic and intravascular ultrasound features on clinical outcome after sirolimus-eluting stent implantation for de-novo lesions in nondiabetic and type 2 diabetic patients.
    Du R; Zhang RY; Zhu ZB; Zhang Q; Hu J; Yang ZK; Yan ZJ; Lv AK; Ding FH; Zhang JS; Shen WF
    Coron Artery Dis; 2010 May; 21(3):175-81. PubMed ID: 20305549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute coronary syndrome is an independent risk factor for late incomplete stent apposition after sirolimus-eluting stent implantation.
    Zhang RY; DU R; Zhu ZB; Zhang Q; Hu J; Lü AK; Zhang JS; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(24):2504-8. PubMed ID: 19187586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-eluting stents: issues of late stent thrombosis.
    Lemesle G; Maluenda G; Collins SD; Waksman R
    Cardiol Clin; 2010 Feb; 28(1):97-105. PubMed ID: 19962052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stent thrombosis following 2 drug-eluting stent implantations for coronary bifurcation lesion: a single-center analysis.
    Gao Z; Xu B; Yang Y; Chen J; Qiao S; Li JJ; Qin X; Wu Y; Yao M; Yuan J; Chen J; Liu H; Dai J; Gao RL
    J Interv Cardiol; 2010 Aug; 23(4):346-51. PubMed ID: 20718906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study.
    Nakazawa G; Finn AV; Joner M; Ladich E; Kutys R; Mont EK; Gold HK; Burke AP; Kolodgie FD; Virmani R
    Circulation; 2008 Sep; 118(11):1138-45. PubMed ID: 18725485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization.
    Finn AV; Joner M; Nakazawa G; Kolodgie F; Newell J; John MC; Gold HK; Virmani R
    Circulation; 2007 May; 115(18):2435-41. PubMed ID: 17438147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated stent thrombosis after DES implantation and localized hypersensitivity to a stent implanted in the distal portion of a coronary aneurysm thought to be a sequela of Kawasaki disease: autopsy report.
    Yokouchi Y; Oharaseki T; Ihara F; Naoe S; Sugawara S; Takahashi K
    Pathol Int; 2010 Feb; 60(2):112-8. PubMed ID: 20398196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for stent thrombosis after implantation of sirolimus-eluting stents in diabetic and nondiabetic patients: the EVASTENT Matched-Cohort Registry.
    Machecourt J; Danchin N; Lablanche JM; Fauvel JM; Bonnet JL; Marliere S; Foote A; Quesada JL; Eltchaninoff H; Vanzetto G;
    J Am Coll Cardiol; 2007 Aug; 50(6):501-8. PubMed ID: 17678732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-eluting versus bare metal stenting in acute myocardial infarction. A clinical review.
    Jones WS; Washam JB; Meine TJ; Patel MR
    Minerva Cardioangiol; 2009 Oct; 57(5):585-95. PubMed ID: 19838149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late thrombosis of paclitaxel-eluting stents: long-term incidence, clinical consequences, and risk factors in a cohort of 604 patients.
    Flores-Ríos X; Marzoa-Rivas R; Abugattás-de Torres JP; Piñón-Esteban P; Aldama-López G; Salgado-Fernández J; Calviño-Santos R; Vázquez-Rodríguez JM; Vázquez-González N; Castro-Beiras A
    Am Heart J; 2008 Apr; 155(4):648-53. PubMed ID: 18371471
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale and design of the Patient Related OuTcomes with Endeavor versus Cypher stenting Trial (PROTECT): randomized controlled trial comparing the incidence of stent thrombosis and clinical events after sirolimus or zotarolimus drug-eluting stent implantation.
    Camenzind E; Wijns W; Mauri L; Boersma E; Parikh K; Kurowski V; Gao R; Bode C; Greenwood JP; Gershlick A; O'Neill W; Serruys PW; Jorissen B; Steg PG;
    Am Heart J; 2009 Dec; 158(6):902-909.e5. PubMed ID: 19958855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry.
    van Werkum JW; Heestermans AA; Zomer AC; Kelder JC; Suttorp MJ; Rensing BJ; Koolen JJ; Brueren BR; Dambrink JH; Hautvast RW; Verheugt FW; ten Berg JM
    J Am Coll Cardiol; 2009 Apr; 53(16):1399-409. PubMed ID: 19371823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stent thrombosis in the era of drug eluting stents.
    Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ST-segment elevation myocardial infarction due to early and late stent thrombosis a new group of high-risk patients.
    Chechi T; Vecchio S; Vittori G; Giuliani G; Lilli A; Spaziani G; Consoli L; Baldereschi G; Biondi-Zoccai GG; Sheiban I; Margheri M
    J Am Coll Cardiol; 2008 Jun; 51(25):2396-402. PubMed ID: 18565395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Very late stent thrombosis after sirolimus-eluting stent implantation observed using optical coherence tomography and coronary angioscopy.
    Ikenaga H; Dai K; Ishihara M
    J Invasive Cardiol; 2010 Nov; 22(11):557-8. PubMed ID: 21041855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry.
    Jensen LO; Tilsted HH; Thayssen P; Kaltoft A; Maeng M; Lassen JF; Hansen KN; Madsen M; Ravkilde J; Johnsen SP; Sørensen HT; Thuesen L
    EuroIntervention; 2010 Apr; 5(8):898-905. PubMed ID: 20542774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stents.
    Novack V; Nguyen MC; Rooney M; Chacko R; Novack L; Pencina M; Apruzzese P; Mauri L; Cohen SA; Moses J; Leon MB; Cutlip DE
    Am J Cardiol; 2010 Sep; 106(6):774-9. PubMed ID: 20816116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.